<?xml version="1.0" encoding="UTF-8" standalone="no"?><information><Cell><NavigationPath><Head00>Maintenance phase</Head00><Stub><StubValue>Number of patients who received a propofol infusion</StubValue></Stub><HeaderValue>Fentanyl (n = 75)</HeaderValue></NavigationPath><value>30 (40%)</value><CellType>Partially Numeric</CellType></Cell><Table><TableType>Matrix</TableType><tableName>Exposure to study opioids and propofol during the maintenance phase (intent to treat population)</tableName><tableOrder>Table 5</tableOrder><tableFooter/></Table><Document><DocumentTitle>Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial [ISRCTN43755713]</DocumentTitle><PMC>420059</PMC></Document></information>